Intravitreal bevacizumab in a patient with neovascular glaucoma.
about
Ranibizumab (Lucentis) versus bevacizumab (Avastin): modelling cost effectivenessThe Ahmed glaucoma valve in neovascular glaucoma (An AOS Thesis)Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalitiesISRCTN12125882 - Influence of topical anti-VEGF (Ranibizumab) on the outcome of filtration surgery for glaucoma - Study Protocol.Neovascular glaucomaAnterior segment changes following intravitreal bevacizumab injection for treatment of neovascular glaucomaAnti-VEGF Agents for Ocular Angiogenesis and Vascular PermeabilitySubconjunctival bevacizumab to augment trabeculectomy with mitomycin C in the management of failed glaucoma surgeryChanges in the retinal vascular network morphology (diameter and tortuosity) after administration of intravitreal bevacizumab in a patient with ischaemic branch retinal vein occlusion.Some ethical considerations for the "off-label" use of drugs such as AvastinThe International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide.Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab.A prospective, randomised, placebo-controlled, double-masked, three-armed, multicentre phase II/III trial for the Study of a Topical Treatment of Ischaemic Central Retinal Vein Occlusion to Prevent Neovascular Glaucoma - the STRONG study: study protThe future implications and indications of anti-vascular endothelial growth factor therapy in ophthalmic practice.Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma: a survey on 23 cases throughout 12-month follow-upIntravitreal bevacizumab in the treatment of neovascular glaucoma secondary to central retinal vein occlusion: a case reportIntravitreal bevacizumab: an analysis of the evidence.Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma.Medical and surgical treatment of neovascular glaucoma.Acute bacterial endophthalmitis after intravitreal bevacizumab injection: Case report and literature review.Bevacizumab in Glaucoma: Where do We Stand?Use of Anti-VEGF Agents in Glaucoma Surgery.Neovascular Glaucoma: A Retrospective Review from a Tertiary Eye Care Center in Mexico.Intravitreal bevacizumab (Avastin) treatment of neovascular glaucoma in ocular ischemic syndrome.Postoperative subconjunctival bevacizumab injection as an adjunct to 5-fluorouracil in the management of scarring after trabeculectomy.Intravitreal bevacizumab with or without mitomycin C trabeculectomy in the treatment of neovascular glaucoma.Intravitreal Avastin for choroidal neovascularisation in pathological myopia: the controversy continues.Intravitreal bevacizumab (avastin) as an adjuvant treatment in cases of neovascular glaucoma.A 65-year-old man with decreased vision OD.Neovascular Glaucoma.Combined Application of Bevacizumab and Mitomycin C or Bevacizumab and 5-Fluorouracil in Experimental Glaucoma Filtration Surgery
P2860
Q24674358-D1D341EB-1024-46DF-A74E-DFDEFD32FB9BQ30437241-81F820FA-850C-4B5F-8AA8-53DE3A0FA76EQ33320830-C6200D3C-1195-4A99-B72C-5252452EEC85Q33795198-A7A80309-76C8-4CA4-8099-959D9D9111ADQ33855412-CE40DCEE-588C-4B1C-99BE-4320235930B4Q33918090-9781379B-83F1-4B5F-9E32-58199560BD98Q34088274-06FF2C07-C170-4DDF-9CB4-F22E0BAF5EB7Q34211999-0CC748C5-451B-418E-85C1-B611C0B259FFQ34792088-6D26B0DE-BB29-4F28-B200-C79A69F31489Q35762558-BA1F9493-86D4-45A1-8817-1AB793800E02Q35762657-A57178AD-B652-4D04-A676-DA0A7F205634Q35872579-B2723982-38E4-4E35-AD2C-32AAD8A06032Q36311337-B2CA1699-C2E0-4395-856D-8A1F53AD4003Q36977441-1639A251-2811-461A-9F3D-A4B1C1162A75Q37142444-5DBDC021-0295-4A7B-8536-2B7A87E8F3F4Q37437644-9E8108FF-04D3-4788-975E-F5A3451A5272Q37577410-10B71E72-1B22-4C80-9D5D-AC9EEB2DCF13Q37672460-88AD07E0-CAEC-4CBF-B6B4-08435ABAB9B8Q37883865-7F1851BC-EC10-4564-913D-2A5A38BA2A77Q38130492-61DE411F-FDB9-4737-9745-11B90280CB4CQ39059786-7CDDFB21-EE42-4D0A-8B23-9A44262B8D21Q41320402-7E2DB197-B0CA-4572-9125-07195F9247E7Q41564442-EE61F165-FFC7-45DE-86C3-36D616FBEF99Q41574069-16F00788-D4E9-4C00-A3E6-5071C4C40E9FQ41590654-49A55B4B-6B57-463E-B358-AEB7F311CBE1Q42789157-27DF9C22-C606-40B4-8749-7226C6717514Q42840733-8129A146-BF63-4249-81CB-E5DE2A0E0D9CQ42927349-0F3340EA-A05C-4C4C-9B8F-2FBAC687F748Q49735221-4C079EE9-15E9-483F-BECF-352E33B9AFADQ54941931-2ED6A334-0522-4943-BDF9-AEB3A5C39A12Q57115822-F2187121-B2C3-4A33-BECD-A31320B7013E
P2860
Intravitreal bevacizumab in a patient with neovascular glaucoma.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Intravitreal bevacizumab in a patient with neovascular glaucoma.
@ast
Intravitreal bevacizumab in a patient with neovascular glaucoma.
@en
type
label
Intravitreal bevacizumab in a patient with neovascular glaucoma.
@ast
Intravitreal bevacizumab in a patient with neovascular glaucoma.
@en
prefLabel
Intravitreal bevacizumab in a patient with neovascular glaucoma.
@ast
Intravitreal bevacizumab in a patient with neovascular glaucoma.
@en
P2093
P1476
Intravitreal bevacizumab in a patient with neovascular glaucoma
@en
P2093
Joel S Schuman
Malik Y Kahook
Robert J Noecker
P304
P577
2006-03-01T00:00:00Z